JOURNAL OF CLINICAL SURGERY ›› 2021, Vol. 29 ›› Issue (11): 1040-1043.doi: 10.3969/j.issn.1005-6483.2021.11.013

Previous Articles     Next Articles

Construction and application of the best evidence-based practice program for nasogastric tube insertion

  

  1. Department of Genneral Surgery,Drum Tower Hospital, School of Medicine, Nanjing University,Jiangsu,Nanjing 210008,China
  • Online:2021-11-20 Published:2021-11-20

Abstract: Objective To explore the clinical practice of best evidence-based practice program for nasogastric tube insertion and evaluate its application.
Methods By referencing to Australia JBI model for evidence-based healthcare, we retrieved and summarized the best evidence for preoperative insertion of nasogastric tube, judged the position of nasogastric tube and alleviated the discomfort caused by the nasogastric tube insertion.Then we formed inspection indicators, maded baseline inspections before application of the best evidence on 29 medical staffs and 50 patients who met the inclusion criteria in department of hepatobiliary surgery, took transformative measures to boost application of the best evidence, and made post-application inspections to evlaute the effect.
Results After the application of the best evidence, the routine operation process of gastric tube insertion was improved; the awareness rate of audit indicators in medical staffs, audit indicators implementation rate, and the correct rate of gastric tube implantation were significantly improved (P<0.05 for all).
Conclusion The summarization and application of the best evidence for preoperative nasogastric tube insertion can improve medical staffs' operation level of nasogastric tube insertion,standardize the operation behaviors,reduce the patients' discomfort caused by the nasogastric tube insertion and improve their satisfaction.

Key words: nasogastric tube insertion, gastrointestinal decompression, comfort, tube position, evidence-based practice program

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 999 -1000 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 1001 .
[3] LIN Ximeng, CHEN Minshan. Clinical features and diagnostic criteria of hepatobiliary duct cell carcinoma[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1004 -1007 .
[4] HUANG Cheng, SUN Huichuan. The road to radical cure in advanced hepatocellular carcinoma——conversion therapy[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1008 -1011 .
[5] WANG Guanyu. Conversion therapy for hepatocellular carcinoma: strategies and current status[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1012 -1014 .
[6] WANG Xiaofei, LI Debao, XIA Feng. Evaluation and research progress of residual liver volume after hepatectomy[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1015 -1018 .
[7] CHEN Jiye, SU Ming, HAN Jun, et al. Laparoscopic anatomic segmental resection of liver[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1018 -1021 .
[8] LIU Zhicheng, GUO Bin, ZHOU Yi, et al. Perioperative adjuvant therapy for hepatocellular carcinoma[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1022 -1024 .
[9] REN Zhangyong, LV Shaocheng, CAO Di, et al.. Pathogenic characteristics and drug resistance of vancomycin resistant enterococci after liver transplantation[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1025 -1028 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1028 -1029 .